Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'MPTP NEUROTOXICITY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 48 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Tsang, KL; Jiang, H; Ramsden, DB; Ho, SL
      The use of estrogen in the treatment of Parkinson's disease

      PARKINSONISM & RELATED DISORDERS
    2. Dluzen, DE; McDermott, JL; Anderson, LI
      Tamoxifen diminishes methamphetamine-induced striatal dopamine depletion in intact female and male mice

      JOURNAL OF NEUROENDOCRINOLOGY
    3. Araki, T; Mizutani, H; Matsubara, M; Imai, Y; Mizugaki, M; Itoyama, Y
      Nitric oxide synthase inhibitors cause motor deficits in mice

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    4. Gao, X; Dluzen, DE
      Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamineneurotoxicity of the nigrostriatal dopaminergic system

      NEUROSCIENCE
    5. Garcia-Segura, LM; Azcoitia, I; DonCarlos, LL
      Neuroprotection by estradiol

      PROGRESS IN NEUROBIOLOGY
    6. Quik, M; Di Monte, DA
      Nicotine administration reduces striatal MPP plus levels in mice

      BRAIN RESEARCH
    7. Obata, T; Yamanaka, Y; Kinemuchi, H; Oreland, L
      Release of dopamine by perfusion with 1-methyl-4-phenylpyridinium ion (MPP+) into the striatum is associated with hydroxyl free radical generation

      BRAIN RESEARCH
    8. Gao, XM; Dluzen, DE
      The effect of testosterone upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system

      BRAIN RESEARCH
    9. Costa, G; Abin-Carriquiry, JA; Dajas, F
      Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra

      BRAIN RESEARCH
    10. Cyr, M; Calon, F; Morissette, M; Grandbois, M; Callier, S; Di Paolo, T
      Drugs with estrogen-like potency and brain activity: Potential therapeuticapplication for the CNS

      CURRENT PHARMACEUTICAL DESIGN
    11. Riedl, AG; Watts, PM; Douek, DC; Edwards, RJ; Boobis, AR; Rose, S; Jenner, P
      Expression and distribution of CYP2C enzymes in rat basal ganglia

      SYNAPSE
    12. German, DC; Liang, CL; Manaye, KF; Lane, K; Sonsalla, PK
      Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons

      NEUROSCIENCE
    13. Yu, L; Liao, PC
      Sexual differences and estrous cycle in methamphetamine-induced dopamine and serotonin depletions in the striatum of mice

      JOURNAL OF NEURAL TRANSMISSION
    14. Yu, L; Liao, PC
      Estrogen and progesterone distinctively modulate methamphetamine-induced dopamine and serotonin depletions in C57BL/6J mice

      JOURNAL OF NEURAL TRANSMISSION
    15. Dluzen, DE
      Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system

      JOURNAL OF NEUROCYTOLOGY
    16. Garcia-Segura, LM; Cardona-Gomez, GP; Chowen, LA; Azcoitia, I
      Insulin-like growth factor-I receptors and estrogen receptors interact in the promotion of neuronal survival and neuroprotection

      JOURNAL OF NEUROCYTOLOGY
    17. Dorman, DC
      An integrative approach to neurotoxicology

      TOXICOLOGIC PATHOLOGY
    18. Tsang, KL; Ho, SL; Lo, SK
      Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations

      NEUROLOGY
    19. Staal, RGW; Hogan, KA; Liang, CL; German, DC; Sonsalla, PK
      In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): Rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    20. Staal, RGW; Sonsalla, PK
      Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    21. Arvin, M; Fedorkova, L; Disshon, KA; Dluzen, DE; Leipheimer, RE
      Estrogen modulates responses of striatal dopamine neurons to MPP+: evaluations using in vitro and in vivo techniques

      BRAIN RESEARCH
    22. Disshon, KA; Dluzen, DE
      Estrogen reduces acute striatal dopamine responses in vivo to the neurotoxin MPP+ in female, but not male rats

      BRAIN RESEARCH
    23. Becker, DA
      Diagnostic and therapeutic applications of azulenyl nitrone spin traps

      CELLULAR AND MOLECULAR LIFE SCIENCES
    24. Yu, JA; Castagnoli, N
      Synthesis and monoamine oxidase B substrate properties of 1-methyl-4-heteroaryl-1,2,3,6-tetrahydropyridines

      BIOORGANIC & MEDICINAL CHEMISTRY
    25. Sadzot, B; Sheldon, J; Flesher, J; Dannals, RF; Schachat, AP; Frost, JJ
      Tracers for imaging melanin with positron emission tomography

      SYNAPSE
    26. Kompoliti, K
      Estrogen and movement disorders

      CLINICAL NEUROPHARMACOLOGY
    27. Miller, GW; Kirby, ML; Levey, AI; Bloomquist, JR
      Heptachlor alters expression and function of dopamine transporters

      NEUROTOXICOLOGY
    28. Ma, SY; Ciliax, BJ; Stebbins, G; Jaffar, S; Joyce, JN; Cochran, EJ; Kordower, JH; Mash, DC; Levey, AI; Mufson, EJ
      Dopamine transporter-immunoreactive neurons decrease with age in the humansubstantia nigra

      JOURNAL OF COMPARATIVE NEUROLOGY
    29. Disshon, KA; Dluzen, DE
      Use of in vitro superfusion to assess the dynamics of striatal dopamine clearance: influence of estrogen

      BRAIN RESEARCH
    30. Brooks, AI; Chadwick, CA; Gelbard, HA; Cory-Slechta, DA; Federoff, HJ
      Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss

      BRAIN RESEARCH
    31. Miller, GW; Gainetdinov, RR; Levey, AI; Caron, MG
      Dopamine transporters and neuronal injury

      TRENDS IN PHARMACOLOGICAL SCIENCES
    32. BEAL MF
      EXCITOTOXICITY AND NITRIC-OXIDE IN PARKINSONS-DISEASE PATHOGENESIS

      Annals of neurology
    33. GAINETDINOV RR; FUMAGALLI F; WANG YM; JONES SR; LEVEY AI; MILLER GW; CARON MG
      INCREASED MPTP NEUROTOXICITY IN VESICULAR MONOAMINE TRANSPORTER-2 HETEROZYGOTE KNOCKOUT MICE

      Journal of neurochemistry
    34. DISSHON KA; BOJA JW; DLUZEN DE
      INHIBITION OF STRIATAL DOPAMINE TRANSPORTER ACTIVITY BY 17-BETA-ESTRADIOL

      European journal of pharmacology
    35. LUCCHI R; NOTARI S; PIERANTOZZI S; BARNABEI O; VILLANI L; POLI A
      EFFECT OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE IN GOLDFISH CEREBELLUM - NEUROCHEMICAL AND IMMUNOCYTOCHEMICAL ANALYSIS

      Brain research
    36. SCHULZ JB; MATTHEWS RT; KLOCKGETHER T; DICHGANS J; BEAL MF
      THE ROLE OF MITOCHONDRIAL DYSFUNCTION AND NEURONAL NITRIC-OXIDE IN ANIMAL-MODELS OF NEURODEGENERATIVE DISEASES

      Molecular and cellular biochemistry
    37. GAINETDINOV RR; FUMAGALLI F; JONES SR; CARON MG
      DOPAMINE TRANSPORTER IS REQUIRED FOR IN-VIVO MPTP NEUROTOXICITY - EVIDENCE FROM MICE LACKING THE TRANSPORTER

      Journal of neurochemistry
    38. DLUZEN D
      ESTROGEN DECREASES CORPUS STRIATAL NEUROTOXICITY IN RESPONSE TO 6-HYDROXYDOPAMINE

      Brain research
    39. KANTHASAMY AG; KANTHASAMY A; MATSUMOTO RR; VU TQ; TRUONG DD
      NEUROPROTECTIVE EFFECTS OF THE STRYCHNINE-INSENSITIVE GLYCINE SITE NMDA ANTAGONIST (R)-HA-966 IN AN EXPERIMENTAL-MODEL OF PARKINSONS-DISEASE

      Brain research
    40. ALBANESE A; GREGORI B; CARRETTA D; TONALI P
      FUNCTIONAL IMPAIRMENT OF NIGROSTRIATAL NEURONS PROGRESSES FOLLOWING WITHDRAWAL OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE

      Neuroscience
    41. GERLACH M; RIEDERER P
      ANIMAL-MODELS OF PARKINSONS-DISEASE - AN EMPIRICAL-COMPARISON WITH THE PHENOMENOLOGY OF THE DISEASE IN MAN

      Journal of neural transmission
    42. ZHANG J; PIEPER A; SNYDER SH
      POLY(ADP-RIBOSE) SYNTHETASE ACTIVATION - AN EARLY INDICATOR OF NEUROTOXIC DNA-DAMAGE

      Journal of neurochemistry
    43. NICKLAS WJ
      COMPLEX-I DEFICIENCY WHAT THE MPTP MODEL TEACHES US

      Clinical neuroscience
    44. ENOCHS WS; SARNA T; ZECCA L; RILEY PA; SWARTZ HM
      THE ROLES OF NEUROMELANIN, BINDING OF METAL-IONS, AND OXIDATIVE CYTOTOXICITY IN THE PATHOGENESIS OF PARKINSONS-DISEASE - A HYPOTHESIS

      Journal of neural transmission. Parkinson's disease and dementia section
    45. SEYFRIED CA; ADAM G
      STUDIES ON THE INTERACTION OF ROXINDOLE WITH BRAIN MONOAMINE OXIDASESAND DOPAMINERGIC-NEURONS IN-VITRO AND IN-VIVO

      Pharmacology & toxicology
    46. DESOLE MS; ESPOSITO G; ENRICO P; MIELE M; FRESU L; DENATALE G; MIELE E; GRELLA G
      EFFECTS OF AGING ON 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) NEUROTOXIC EFFECTS ON STRIATUM AND BRAIN-STEM IN THE RAT

      Neuroscience letters
    47. LIPTROT J; HOLDUP D; PHILLIPSON O
      ,2,3,4-TETRAHYDRO-2-METHYL-4,6,7-ISOQUINOLINETRIOL DEPLETES CATECHOLAMINES IN RAT-BRAIN

      Journal of neurochemistry
    48. CHAN P; LANGSTON JW; IRWIN I; DELANNEY LE; DIMONTE DA
      2-DEOXYGLUCOSE ENHANCES METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-INDUCED ATP LOSS IN THE MOUSE-BRAIN

      Journal of neurochemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/05/20 alle ore 14:24:00